Issued Patents All Time
Showing 1–17 of 17 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11858991 | LAG-3-binding molecules and methods of use thereof | Ross La Motte-Mohs, Douglas H. Smith, Leslie S. Johnson, Paul A. Moore, Ezio Bonvini +1 more | 2024-01-02 |
| 11840571 | Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4 | Leslie S. Johnson, Gurunadh Reddy Chichili, Ross La Motte-Mohs, Paul A. Moore, Ezio Bonvini +1 more | 2023-12-12 |
| 11820818 | Multi-chain polypeptide-containing tri-specific binding molecules | Leslie S. Johnson, Ling Huang, Gurunadh Reddy Chichili, Chia-Ying Kao Lam, Stephen James Burke +4 more | 2023-11-21 |
| 11697684 | Tri-specific binding molecules that specifically bind to multiple cancer antigens | Ezio Bonvini, Paul A. Moore, Jonathan Li, Leslie S. Johnson | 2023-07-11 |
| 11623959 | PD-1-binding molecules and methods of use thereof | Douglas H. Smith, Ross La Motte-Mohs, Leslie S. Johnson, Paul A. Moore, Ezio Bonvini +1 more | 2023-04-11 |
| 11384149 | Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof | Leslie S. Johnson, Ling Huang, Ezio Bonvini, Paul A. Moore, Wei Chen | 2022-07-12 |
| 11098119 | Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof | Ezio Bonvini, Leslie S. Johnson, Ross La Motte-Mohs, Paul A. Moore, Scott Koenig | 2021-08-24 |
| 11072653 | LAG-3-binding molecules and methods of use thereof | Ross La Motte-Mohs, Douglas H. Smith, Leslie S. Johnson, Paul A. Moore, Ezio Bonvini +1 more | 2021-07-27 |
| 10954301 | Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereof | Leslie S. Johnson, Gurunadh Reddy Chichili, Ross La Motte-Mohs, Paul A. Moore, Ezio Bonvini +1 more | 2021-03-23 |
| 10858430 | Bi-specific monovalent diabodies that are capable of binding to gpA33 and CD3, and uses thereof | Paul A. Moore, Jonathan Li, Francine Zhifen Chen, Leslie S. Johnson, Ezio Bonvini | 2020-12-08 |
| 10647768 | Multi-chain polypeptide-containing tri-specific binding molecules | Leslie S. Johnson, Ling Huang, Gurunadh Reddy Chichili, Chia-Ying Kao Lam, Stephen James Burke +4 more | 2020-05-12 |
| 10633440 | Multi-chain polypeptide-containing tri-specific binding molecules that specifically bind to multiple cancer antigens | Ezio Bonvini, Paul A. Moore, Jonathan Li, Leslie S. Johnson | 2020-04-28 |
| 10577422 | PD-1-binding molecules and methods of use thereof | Douglas H. Smith, Ross La Motte-Mohs, Leslie S. Johnson, Paul A. Moore, Ezio Bonvini +1 more | 2020-03-03 |
| 10501552 | Multivalent molecules comprising DR5-binding domains | Paul A. Moore, Leslie S. Johnson, Jonathan Li | 2019-12-10 |
| 10344092 | Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof | Leslie S. Johnson, Ling Huang, Ezio Bonvini, Paul A. Moore, Wei Chen | 2019-07-09 |
| 10160806 | Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof | Ezio Bonvini, Leslie S. Johnson, Ross La Motte-Mohs, Paul A. Moore, Scott Koenig | 2018-12-25 |
| 9932400 | Bi-specific monovalent diabodies that are capable of binding to gpA33 and CD3, and uses thereof | Paul A. Moore, Jonathan Li, Francine Zhifen Chen, Leslie S. Johnson, Ezio Bonvini | 2018-04-03 |